LOTUSEYE Stock View

Lotus Eye Hospital and Institute Ltd

LOTUSEYE

(NSE)

Trade

₹ 57.9

0.95 | 1.61

Market Cap ₹( Cr.)
1,204.11

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
26-Mar-2023

 

Copy Link

Lotus Eye Hospital and Institute Limited is an India-based company, which offers healthcare services. The Company operates primarily in the field of ophthalmology (Eye) and its related operation. The Company has equipped specialty clinics, such as Cataract, Glaucoma, Cornea, Pediatric Ophthalmology, Retina and Oculoplasty. It also has a LASIK Centre which is equipped with ALCON’s WaveLight Ex500 Excimer Laser which provides the technology for an advanced LASIK procedure. The Company’s services include clinical services, patient services and allied services. Clinical service provides eye care, cataract, cornea, glaucoma, retina, oculoplasty, pediatric, ophthalmology and strabismus, refractive surgery (LASIK, PRK, ASA, LASEK), community ophthalmology and low vision aid. Patient service offers both out-patient services and in-patient services. Its allied service operates lotus ayurvedic center and optical center.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data